BioCentury's websites will be down for upgrades starting at 9 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

5:39 PM
 | 
Oct 26, 2007
 |  BC Extra  |  Company News

Kosan, Roche ending cancer deal

KOSN and Roche (SWX:ROG) will end a 2002 deal to develop and commercialize epothilone compounds to treat cancer. KOSN said it believed ROG's decision was "driven by a re-prioritization within Roche's research and development group rather than...

Read the full 166 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >